We won’t overcharge you through a subscription model. Our one off economical prices remain fixed all the time

Check Eligibility
From
£85/month
  • GLP-1 Specialist Clinicians · UK Registered
    Reviewed within 1 working day

Clinician-led weight management for  Obstructive Sleep Apnoea.

Weight is the primary modifiable factor in sleep apnoea. Our GLP-1 specialist clinicians provide medicated weight management that addresses the root cause — not just the symptoms. No GP referral needed.
Check My Eligibility

Takes 5 minutes
· No commitment · Reviewed within 1 working day

  • No GP referral needed
  • GLP-1 specialist clinicians
  • 3-weekly check-ins
  • Fully online
  • Results may vary
photo 1571019613454 1cb2f99b2d8b
Programme members
10%
weight loss = up to 50% AHI reduction
Ellipse 276 3
Ellipse 275 (3)
Ellipse 274 (4)
Obstructive Sleep Apnoea
Ellipse 276 3
1.5M

UK adults estimated to have OSA — most undiagnosed

Excess weight is the primary cause of OSA in the majority of cases. Even modest weight reduction significantly reduces AHI events and daytime sleepiness.

Source:  British Lung Foundation / Sleep Apnoea Trust, 2024 · View source ↗

The Challenge

Sleep apnoea doesn't just disrupt sleep — it damages your heart, metabolism, and daily life

CPAP treats the symptom — clinician-managed weight loss treats the cause

CPAP machines keep your airway open. They do not address why it collapses. For the majority of people with OSA, excess adipose tissue around the neck and pharynx is the primary cause. GLP-1 medicated weight management targets this directly.
📖 Iftikhar IH et al., Meta-analysis of CPAP vs weight loss for OSA, Sleep Medicine, 2013

Poor sleep drives weight gain — creating a vicious cycle

OSA causes fragmented sleep. Sleep deprivation raises ghrelin (hunger hormone) and lowers leptin (satiety hormone). This makes weight gain more likely and weight loss harder — a cycle that GLP-1 medication is specifically positioned to break.
📖 Beccuti G, Pannain S, Best Practice & Research Clinical Endocrinology & Metabolism, 2011

Long waits can delay progress

When weight is affecting your health, waiting months for support can feel frustrating. WeightFall gives you faster access to clinician-led weight management, starting with a review within 1 working day
📖 Young T et al., The occurrence of sleep-disordered breathing, NEJM, 1993
50%
Ellipse 655

reduction in AHI events achievable with 10% body weight reduction in OSA

📖 Peppard PE et al., JAMA, 2000
1.5M
Ellipse 655

estimated UK adults with OSA — majority remain undiagnosed

📖 British Lung Foundation / Sleep Apnoea Trust, 2024
Ellipse 655 (1)
Ellipse 656 (1)

No need for subscriptions,

get weight management programme through us for the lowest price
The Programme Approach

A clinician-managed
programme built around your condition

WeightFall combines GLP-1 medication with specialist clinical oversight a managed programme, not just a prescription service.
Clinician-prescribed · Condition-aware

Medicated Weight Management

GLP-1 medication assessed and prescribed by your GLP-1 specialist clinician, with dose titration specifically calibrated to your diabetes medication history, blood sugar control, and health profile.
01
Regular · Adaptive · Ongoing

3-Weekly Clinician Check-ins

Your dedicated GLP-1 specialist reviews your progress every 3 weeks — adjusting your dose, managing side effects, and evolving your plan as you respond. Not a one-off consultation.
02
Food · Movement · Mindset

Lifestyle & Habit Guidance

Food, movement, sleep and mindset coaching alongside your medication — with specific guidance on managing blood sugar through lifestyle, not just medication.
03
  • All treatments are subject to individual clinical assessment by a UK-registered clinician. Your clinician determines clinical suitability before any commitment is made. WeightFall is a managed weight management programme — not a substitute for your existing medical care. Always maintain your GP-prescribed treatments unless advised by a clinician.
Check My Eligibility
GLP-1 specialist clinicians · Reviewed within 1 working day
Member Stories

Real people, Verified outcomes

Condition-specific health metrics — not just numbers on a scale.
“After losing 16kg my sleep study showed my AHI dropped from severe to mild. My sleep specialist said they’d never seen that improvement so fast. I sleep without CPAP most nights now.”
-14kg
Weight Loss
4.2→2.1
Triglycerides (mmol/L)
Weightfall clinical team
Sarah Jenkins
Member since 2023
“The 3-weekly clinician check-ins tracked every change. Once the weight started moving, my daytime sleepiness improved dramatically. I feel like myself again.”
-9kg
Weight Loss
↓ 1.4
mmol/L reduction
Weightfall clinical team 2
David Miller
Member since 2024
“My goal was to reduce CPAP dependency. I’m not off it yet but 2 nights a week is a transformation from 7. My sleep specialist confirmed the progress was consistent with my weight loss.”
-8kg
Weight Loss
↑ 0.3
mmol/L improvement
Weightfall clinical team 2
David Miller
Member since 2024
Check My Eligibility
Takes 5 minutes · No commitment · Reviewed within 1 working day
The WeightFall Programme

Everything included — from £85/month

Every WeightFall programme includes the same level of clinical oversight, support and monitoring — regardless of which treatment your clinician recommends.

Clinical assessment & review

Your case reviewed by a GLP-1 specialist clinician before treatment begins. Condition-specific. Thorough. Personal.

Check-in every 3 weeks

Regular clinician review of your progress, dose and side effects. You’re never left to figure it out between appointments.

Dose adjustment support

Your plan adapts as you respond to treatment — no fixed templates. Dose escalation managed by your specialist throughout.

Lifestyle & habit guidance

Food, movement, sleep and mindset coaching alongside your treatment. Sustainable change, not just medication.

Fully online — no GP referral

Everything managed from home. A UK-registered clinician reviews your case and responds within 1 working day. Completely private.

Secure & confidential

Your health data handled with full clinical confidentiality. GDPR compliant. Secure encrypted platform.
Individual results vary. Data based on published clinical trial evidence. Your clinician will set realistic expectations for your specific case at assessment.

Your weight management journey

Week 1–4
Programme begins
Clinician reviews your case, dosing starts. First check-in at week 3. Most patients notice reduced appetite early on.
Month 1–3
Early progress
Appetite changes become more consistent. Dose adjusted as needed.
Month 3–6
Meaningful change
Progressive dose increases. Body weight reduction. Lifestyle coaching integrated alongside medication.
Month 6–12
Sustained results
Clinical trial shows body weight reduction. Clinician guides maintenance or tapering.
Programmes from
£85/month
Price varies by treatment type and dose. Your clinician confirms before any commitment.
  • Clinical assessment & review by GLP-1 specialist
  • Check-in every 3 weeks throughout your programme
  • Dose adjustment — no fixed templates
  • Lifestyle & habit guidance included
  • Fully online — no GP referral needed
  • Secure & confidential — your data protected
Check My Eligibility
If you’re not clinically eligible, you won’t be charged for treatment.
  • All treatments are subject to clinical assessment. WeightFall does not guarantee any specific health or weight outcome. Results depend on individual health status and adherence. Individual results vary significantly. Your clinician will set realistic expectations specific to your case.

Evidence-based. Peer-reviewed. Regulated.

Every element of the WeightFall programme is grounded in clinical evidence. Our approach is informed by the highest-quality published studies — and updated as new evidence emerges.
01
Peppard PE et al. — JAMA 2000
10% weight gain was associated with a 6× increase in OSA risk. Conversely, weight loss produced dose-dependent reductions in AHI events.
Read full study
02
Chirinos JA et al. — NEJM 2014
Weight loss combined with CPAP produced greater improvements in sleepiness, mood, and cardiometabolic markers than CPAP alone in OSA patients with obesity.
Read full study
03
Beccuti G, Pannain S — 2011
Sleep deprivation from OSA drives metabolic dysfunction including insulin resistance and hyperphagia — creating a self-perpetuating weight-sleep cycle that GLP-1 medication can help break.
Read full study

Regulatory statement (CAP Code 12.1): WeightFall is a clinician-led weight management service. All treatments are prescription-only and subject to clinical assessment by UK- registered clinicians. WeightFall does not diagnose, treat, or cure any medical condition. Clinicians are registered with the General Medical Council (GMC). This service is not a substitute for NHS care.

Your questions, answered

Condition-specific answers — straight from our clinical team.

Find Out If You're Eligible

We’ll ask you a few quick questions to help determine your eligibility for treatment. Your responses will remain private and confidential.
Check My Eligibility
Frame 1321315189 1
Is this a medical treatment for sleep apnoea?
No. WeightFall provides clinician-led medicated weight management. It does not treat OSA. Some patients see reductions in sleep apnoea severity — but this is not guaranteed.
No — individual results vary significantly. No specific OSA or health outcome is guaranteed.
No. Never stop using your CPAP without your sleep specialist’s explicit advice. CPAP is a prescribed medical device. Any changes to CPAP usage should be made only under specialist supervision.
We cannot make this claim. Evidence shows weight loss can significantly reduce OSA severity in many people — but outcomes vary individually. Your clinician will set realistic expectations at assessment.
Every 3 weeks your GLP-1 specialist clinician reviews your progress, weight, side effects, and plan. All online — no appointments needed.
Yes. WeightFall is a private programme that runs alongside NHS sleep services. Maintain all NHS appointments and do not change prescribed treatments without specialist guidance.
Not without consent. With permission, we can share progress summaries with your relevant clinicians.
If a clinician determines treatment isn’t appropriate, your payment for that order is refunded.
First treatment dose, clinical assessment review, clinician sign-off, and first 3-weekly check-in. Prices vary by treatment type and dose — full breakdown before commitment.
No. Treatment is reviewed continuously. Your clinician guides you on tapering if you choose to stop.
Some patients report improved energy and sleepiness scores within 6–8 weeks. Meaningful AHI changes typically require more sustained weight loss. Individual results vary significantly.
Yes. Our UK-registered clinicians assess your suitability independently based on your health history, BMI, and relevant conditions.